Stage II Seminoma: Why Chemotherapy Should Remain a Standard

Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 71, 209, 10.3322/caac.21660 Giannatempo, 2015, Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes, Ann Oncol, 26, 657, 10.1093/annonc/mdu447 Daneshmand, 2021, SEMS trial: result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma, J Clin Oncol, 39, 375, 10.1200/JCO.2021.39.6_suppl.375 Albers, 2022, The PRIMETEST trial: prospective phase II trial of primary retroperitoneal lymph node dissection (RPLND) in stage II A/B patients with seminoma, J Clin Oncol, 40, 420, 10.1200/JCO.2022.40.6_suppl.420 Oldenburg, 2022, Testicular seminoma and non-seminoma: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up, Ann Oncol, 33, 362, 10.1016/j.annonc.2022.01.002 Chung, 2004, Stage II testicular seminoma: patterns of recurrence and outcome of treatment, Eur Urol, 45, 754, 10.1016/j.eururo.2004.01.020 Fizazi, 2014, A Risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study, Eur Urol, 65, 381, 10.1016/j.eururo.2013.09.004 Gillessen, 2021, Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): results from the IGCCCG Update Consortium, J Clin Oncol, 39, 1563, 10.1200/JCO.20.03296 Fung, 2017, Multi-institutional assessment of adverse health outcomes among North American testicular cancer survivors after modern cisplatin-based chemotherapy, J Clin Oncol, 35, 1211, 10.1200/JCO.2016.70.3108 Loriot, 2022, The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography, Eur Urol, 82, 172, 10.1016/j.eururo.2022.04.031 Papachristophilou, 2021, Single-dose carboplatin followed by involved-node radiotherapy as curative treatment for seminoma stage IIA/B: Efficacy results from the international multicenter phase II trial SAKK 01/10, Ann Oncol, 32, S1283 Mego, 2019, Clinical utility of plasma miR-371a-3p in germ cell tumors, J Cell Mol Med, 23, 1128, 10.1111/jcmm.14013